序号 |
标题 |
次数 |
作者 |
发布时间 |
86536 |
单-6-(4-甲基丙烯酸丙炔基酯-1,2,3-三氮唑)-环糊精 |
98 |
WYQ |
2024-11-22 |
86537 |
DOTA-CH2-Ph-azide(HCl salt) |
70 |
wyh |
2024-11-22 |
86538 |
204318-14-9,Edotreotide ,DOTA-TOC,DOTA-(酪氨酸3)-奥曲肽 |
97 |
kx |
2024-11-22 |
86539 |
CAS:911197-00-7 Propargyl-DOTA-tris(tBu)ester |
98 |
zyl |
2024-11-22 |
86540 |
罗丹明B,1-O-丙炔基-2,3,4,6-四-O-乙酰基-β-D-葡萄糖苷 |
111 |
WYQ |
2024-11-22 |
86541 |
DOTA-UAMC1110 DOTA螯合剂偶联FAP抑制剂(UAMC1110) |
137 |
zcy |
2024-11-22 |
86542 |
1-(1,3-二苯基-2-丙炔基)-哌啶 |
102 |
WYQ |
2024-11-22 |
86543 |
p-SCN-Bn-DOTA;127985-74-4 |
89 |
wyh |
2024-11-22 |
86544 |
(S)-5-氯-α-环丙炔基-2-氨基-α-三氟甲基苯甲醇 |
127 |
WYQ |
2024-11-22 |
86545 |
DOTA-NHS ester,四氮杂环十二烷四乙酸-琥珀酰亚胺酯 |
101 |
kx |
2024-11-22 |
86546 |
cas:149819-85-2 Iron DOTA Sodium Salt |
93 |
zyl |
2024-11-22 |
86547 |
Maleimide-DOTA ;1006711-90-5 |
98 |
wyh |
2024-11-22 |
86548 |
Cy3标记的血清聚糖 齐岳定制 |
82 |
zcy |
2024-11-22 |
86549 |
DOTA-tris (t-Bu ester) |
108 |
kx |
2024-11-22 |
86550 |
Dota-Eb-Tate Dota偶联生长抑素类似物 |
117 |
zcy |
2024-11-22 |
86551 |
2-Aminoethyl-mono-amide-DOTA-tris(tBu ester) ;173308-19-5 |
96 |
wyh |
2024-11-22 |
86552 |
DOTA-TRI(ACID)-酰胺-三聚乙二醇-溴乙酰胺 |
93 |
zyl |
2024-11-22 |
86553 |
DOTA mono-NHS ester |
103 |
kx |
2024-11-22 |
86554 |
DOTA-Peptide 2 DOTA螯合多肽 |
95 |
zcy |
2024-11-22 |
86555 |
DOTA-peg-TAT ;大环配体-聚乙二醇- 穿膜肽 |
97 |
wyh |
2024-11-22 |
86556 |
cas:250612-06-7 DOTA-Glu[cyclo(Arg-Gly-Asp-D-Phe-Lys)]2 |
118 |
wyh |
2024-11-22 |
86557 |
DOTA-Glu(cyclo(Arg-Gly-Asp-DPhe-Lys))2 |
119 |
kx |
2024-11-22 |
86558 |
NHS偶联的DOTA螯合剂 DOTA-NHS |
269 |
zcy |
2024-11-22 |
86559 |
DOTA-三(酸) - 酰氨基-DPEG(R)12-TFP酯 |
123 |
zyl |
2024-11-22 |
86560 |
Ga-68 DOTA-TATE,镓-68标记的生长抑素类似物DOTA-TATE |
645 |
wyh |
2024-11-22 |
86561 |
Gd-EOB-DTPA的结构组成 |
304 |
kx |
2024-11-22 |
86562 |
DOTA-TRIS(TBE)-AMIDO-DPEG(R)12-TFP酯 |
118 |
zyl |
2024-11-22 |
86563 |
Fmoc-L-Lys-mono-amide-DOTA-tris(t-Bu ester) ;479081-06-6 |
105 |
wyh |
2024-11-22 |
86564 |
CAS:2125661-62-1 BUTYNE-DOTA 炔基 双功能螯合剂 |
171 |
zyl |
2024-11-22 |
86565 |
619300-53-7,DOTA多肽分子探针,DOTA NOC acetate |
103 |
kx |
2024-11-22 |
86566 |
p-NCS-Bz-DOTA-GA |
114 |
wyh |
2024-11-22 |
86567 |
Lysine-DOTA CAS号:508172-24-5 |
91 |
zyl |
2024-11-22 |
86568 |
5-Gd-DOTA-CS的组成与结构、功能与应用 |
123 |
kx |
2024-11-22 |
86569 |
CAS:1670260-54-4 DOTA-tris(t-Bu)-Amido-PEG7-Azide |
100 |
zyl |
2024-11-22 |
86570 |
三叔丁基1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸;137076-54-1 |
96 |
wyh |
2024-11-22 |
86571 |
cas:1823122-52-6 ;DOTA-NHS-ester TFA |
130 |
wyh |
2024-11-22 |
86572 |
四氮杂环十二烷四乙酸-琥珀酰亚胺酯 |
112 |
kx |
2024-11-22 |
86573 |
DOTA-Acrylamide,DOTA-丙烯酰胺,双功能螯合剂 |
107 |
zyl |
2024-11-22 |
86574 |
cas: 819869-77-7;DOTA-tris(tBu)ester NHS ester |
110 |
wyh |
2024-11-22 |
86575 |
Ga-DOTA-FAPI/ANCP-PSMA ,镓-大环配体-蛋白抑制剂 |
250 |
kx |
2024-11-22 |
86576 |
DOTA-Octreotide,DOTATATE |
128 |
wyh |
2024-11-22 |
86577 |
10-[2-[(3,5-Dicarboxyphenyl)amino]-2-oxoethyl]-DOTA (TFA salt) |
142 |
wyh |
2024-11-22 |
86578 |
(N3-PEG4)-(DOTA)-3K的基本组成 |
137 |
wyh |
2024-11-22 |
86579 |
909024-55-1,DOTA-cyclo(RGDfK) acetate |
116 |
kx |
2024-11-22 |
86580 |
11β[4(-N,N-二甲氨基)]苯基-17β-羟基-17α(-1-丙炔基)-雌甾-4,9-二烯-3-酮 |
143 |
WYQ |
2024-11-22 |